Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: J Invest Dermatol. 2016 Jan;136(1):339–342. doi: 10.1038/JID.2015.374

Figure 1.

Figure 1

Association of the mutational status and the methylation profile of the TERT promoter with disease characteristics and outcome data for 23 patients with melanocytic tumors. The 26 CpG sites were aberrantly methylated in wild-type TERT promoter melanomas (the last 4 rows) but were predominantly unmethylated in low-grade or benign melanocytic tumors (atypical spitzoid neoplasms and GCN with proliferative nodules) and in mutant TERT promoter melanomas. Methylation panel color code: M, methylated; PM, partially methylated; PUM, partially unmethylated; UM, unmethylated; NA, not available.